Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDairy Crest Regulatory News (DCG)

  • There is currently no data for DCG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

31 Jan 2019 07:00

RNS Number : 5883O
Dairy Crest Group PLC
31 January 2019
 

31 January 2019

 

Dairy Crest Group plc ("Dairy Crest")

 

Trading Update

Strong Third Quarter; Full Year In Line With Expectations

 

Dairy Crest is today issuing a Trading Update for the nine months ended 31 December 2018.

 

The company's key brands - Cathedral City, Clover, Country Life and Frylight - all delivered strong volume and revenue growth for the third quarter ended 31 December 2018. On a combined basis, the four brands generated revenue growth of around 10% for the third quarter and 6% for the nine months ended 31 December 2018.

 

In line with our expectations at the time of the Interim Results, Cathedral City had a particularly good third quarter. Both volume and revenue grew by around 10%, helped in part by new product launches, including flavoured snack bars, Lactose Free and a refreshed kids' snacking range.

 

Dairy Crest's spreads brands continue to gain market share. Clover Light with no artificial ingredients was launched in August 2018 and has been voted 'Product of the Year' in the UK spreads category in the world's largest consumer survey for product innovation.

 

Frylight returned to double digit volume and revenue growth in the third quarter, although over the nine month period the brand declined due to the challenging first half of the year.

 

Following a reduction in cream prices, we started to promote Country Life again which led to positive volume and revenue growth in the quarter. The partnership with English Heritage offering 2 for 1 entry began this month.

 

Demand for our functional ingredients - demineralised whey powder and galacto-oligosaccharides (GOS) - continues to increase. In January 2019, daily Promovita GOS 'shots' for consumers went on sale for the first time.

  

There is significant uncertainty around Brexit and the impact of a potentially disorderly exit is hard to predict. Whilst our supply chain and customer base are primarily located in the UK, we are taking steps to reduce our exposure, including accelerating the purchase of ingredients and packaging materials.

 

Notwithstanding this, the outlook for the full year remains in line with our expectations.

 

Mark Allen, Chief Executive of Dairy Crest, commented:

"Our key brands have delivered exceptional performance in the third quarter with all four generating both volume and revenue growth. Demand for our functional ingredients is also increasing, with positive implications for price.

 

"We have launched several major innovations during the past nine months. It is gratifying to have received external validation of one our most technologically advanced achievements, Clover Light with No Artificial Ingredients, by winning 'Product of the Year 2019'. This is the third consecutive year that one of our products has been awarded this accolade."

 

Dairy Crest will issue its Preliminary Results for the year ended 31 March 2019 on23 May 2019.

 

For further information:

Investors/Analysts

 

 

 

Tom Atherton

 

Dairy Crest

01372 472264

Kate Goode

 

Dairy Crest

01372 472236

 

 

 

 

Media

 

 

 

Tim Danaher/Alison Lea

Brunswick

020 7404 5959

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFFRLTIIVIA
Date   Source Headline
31st Jan 201811:43 amRNSTotal Voting Rights & Capital
31st Jan 20187:00 amRNSTrading Update
26th Jan 20182:51 pmRNSDirector/PDMR Shareholding
18th Jan 20183:53 pmRNSDirector and PCA Dealing
17th Jan 20187:00 amRNSExecutive Director Notification
9th Jan 201810:28 amRNSDirector / PDMR Shareholding
3rd Jan 20183:39 pmRNSDirector/PDMR Shareholding
2nd Jan 20189:38 amRNSTotal Voting Rights & Capital
5th Dec 20179:29 amRNSTR-1
30th Nov 201710:43 amRNSTotal Voting Rights & Capital
28th Nov 20177:00 amRNSNon-Executive Director Appointment
22nd Nov 20172:17 pmRNSStandard form for notification of major holdings
20th Nov 201710:40 amRNSDirector/PDMR Shareholding
13th Nov 201710:28 amRNSStandard form for notification of major holdings
9th Nov 20177:00 amRNSInterim Results
3rd Nov 20171:56 pmRNSTotal Voting Rights
2nd Oct 20177:00 amRNSTotal Voting Rights
21st Sep 201712:11 pmRNSTR-1: form for notification of major holdings
18th Sep 20177:00 amRNSTrading Statement
8th Sep 20177:00 amRNSActuarial valuation agreed for the pension fund
4th Sep 20172:37 pmRNSDirector / PDMR Shareholding
31st Aug 20171:42 pmRNSTotal Voting Rights
17th Aug 20172:03 pmRNSDirector / PDMR Shareholding
15th Aug 201710:15 amRNSDirector/PDMR Shareholding
9th Aug 201710:12 amRNSBLOCK LISTING SIX MONTHLY REVIEW
31st Jul 201712:11 pmRNSTotal Voting Rights & Capital
18th Jul 20174:51 pmRNSResults of Annual General Meeting
18th Jul 20177:00 amRNSAGM and Interim Management Statement
7th Jul 20171:36 pmRNSDirector/PDMR Shareholding
30th Jun 20172:30 pmRNSTotal Voting Rights
30th Jun 201711:15 amRNSTotal Voting Rights
16th Jun 201710:43 amRNS2017 Annual Report & Accounts & Notice of AGM
2nd Jun 201710:36 amRNSTotal Voting Rights
26th May 20173:54 pmRNSDirector / PDMR Shareholding
19th May 201712:47 pmRNSBlock Listing Six Monthly Review
18th May 20177:00 amRNSPreliminary Results
28th Apr 201710:40 amRNSTotal Voting Rights
12th Apr 201712:02 pmRNSNotification of Major Interest in Shares
31st Mar 20179:21 amRNSTotal Voting Rights & Capital
2nd Mar 20173:16 pmRNSTotal Voting Rights
9th Feb 20177:00 amRNSInterim Management Statement
31st Jan 201711:29 amRNSTotal Voting Rights & Capital
27th Jan 201712:51 pmRNSDirector/PDMR Shareholding
10th Jan 20171:38 pmRNSDirector / PDMR Shareholding
10th Jan 20171:27 pmRNSDirector / PDMR Shareholding
10th Jan 20171:24 pmRNSDirector / PDMR Shareholding
3rd Jan 201710:59 amRNSTotal Voting Rights
21st Dec 20167:00 amRNSDairy Crest announces research partnership
30th Nov 201612:58 pmRNSTotal Voting Rights & Capital
24th Nov 20161:02 pmRNSBLOCK LISTING SIX MONTHLY REVIEW

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.